Invezz

Piper Sandler Companies (PIPR)

NYSE Market Closed

Piper Sandler Companies is an investment bank and institutional securities firm serving corporate clients, financial sponsors, public sector issuers, nonprofit organizations, and institutional investors. Headquartered in the United States with an international reach, the firm provides advice and execution across mergers and acquisitions, capital raising, public finance, equity and fixed income markets, research, brokerage, and alternative asset management.

The company is best known for middle-market investment banking, where it advises companies and private equity groups on strategic transactions. Its advisory business is a major revenue driver and includes M&A, restructuring, fairness opinions, and other corporate finance assignments. Piper Sandler also helps clients access capital through equity and debt offerings, with sector expertise across areas such as healthcare, financial services, consumer, energy, technology, and diversified industrials.

Beyond corporate investment banking, Piper Sandler has a significant public finance franchise that works with state and local governments, school districts, healthcare systems, and other public entities. Its institutional securities operations provide sales, trading, and research services to asset managers, banks, insurance companies, hedge funds, and other professional investors. The firm’s research platform covers equities and macro themes, supporting both investor clients and capital markets activity.

PIPR is exposed to cycles in dealmaking, market volatility, interest rates, investor risk appetite, and new issuance activity. When mergers, acquisitions, IPOs, and debt financings are active, fee opportunities generally improve; when markets weaken, advisory and underwriting volumes can slow. The company’s appeal lies in its specialized sector knowledge, broad institutional relationships, and diversified mix of advisory, financing, public finance, brokerage, and asset management services.

76.26 USD
−0.98 (-1.27%)

Last updated

Market Cap
$5,219,680,616
P/E
18.53
P/FCF
10.96
P/S
2.58
Enterprise Value
$4,890,246,616
Sector
Financials
Industry
Investment Banking & Brokerage
Address
350 NORTH 5TH STREET, SUITE 1000, MINNEAPOLIS, MN, 55401
yahoo.com

Piper cautious on SpaceX, points to near-term headwinds

16 Jul 2026, 20:47 PM
yahoo.com

Piper Sandler and PJT Shares Skyrocket, What You Need To Know

15 Jul 2026, 04:49 AM
investing.com

Tesla’s Earnings Loom With Almost No Room for Error

16 Jan 2026, 01:02 AM
globenewswire.com

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares

03 Dec 2025, 08:41 AM
globenewswire.com

Amneal to Participate in Upcoming Investor Conferences

02 Dec 2025, 18:30 PM
globenewswire.com

Information relating to the stabilization activities carried out in the context of its recent offering

25 Nov 2025, 02:30 AM
globenewswire.com

Axsome Therapeutics to Participate in Upcoming Investor Conferences

20 Nov 2025, 17:30 PM
globenewswire.com

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

18 Nov 2025, 17:30 PM
globenewswire.com

Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares

14 Nov 2025, 09:37 AM
globenewswire.com

BillionToOne Announces Pricing of Upsized Initial Public Offering

06 Nov 2025, 08:23 AM
globenewswire.com

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

17 Oct 2025, 09:15 AM
globenewswire.com

Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)

15 Oct 2025, 01:30 AM
globenewswire.com

Inventiva Announces the Implementation of a New ATM Program

15 Oct 2025, 01:30 AM
globenewswire.com

Esperion Announces Pricing of Public Offering of Common Stock

08 Oct 2025, 06:59 AM
globenewswire.com

LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering

11 Sept 2025, 06:33 AM
globenewswire.com

Great Elm Capital Corp. Prices Public Offering of $50 Million of 7.75% Notes Due 2030

05 Sept 2025, 03:06 AM
globenewswire.com

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

13 Aug 2025, 07:58 AM
Market Cap
$5,219,680,616
Enterprise Value
$4,890,246,616
P/E
18.53
P/B
3.89
P/S
2.58
EV / EBITDA
11.13
EV / Sales
2.42
EPS
4.17
Dividend Yield
2.77%
P/FCF
10.96
P/CF
10.39
Free Cash Flow
$476,463,000
ROE
20.99%
ROA
13.22%
Debt / Equity
0.01
Current Ratio
2.67
Quick Ratio
2.67
Cash
1.4
Avg Volume
$629,335
Fundamentals Snapshot Price
77.24

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 475.15M 666.99M 480.09M 398.58M 358.55M
Cost of revenue 736K 942K 818K 1.8M 1.28M
Gross profit 474.41M 666.05M 479.28M 396.78M 357.27M
Operating income 87.93M 188.76M 107.43M 48.92M 29.43M
EBITDA 87.93M 188.87M 108.47M 53.92M 29.43M
Net income 65.24M 113.97M 60.27M 42.18M 64.92M
Income taxes 19.62M 45.8M 24.95M 17.17M -7.34M
Other operating expenses 28.58M 29.42M 25.95M 29.34M 15.37M
Total operating expenses 386.48M 477.29M 371.85M 347.85M 327.84M
Basic EPS 0.96 1.7 0.9 0.63 0.99
Diluted EPS 0.92 1.6 0.85 0.6 0.91

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 2.13B 2.59B 2.22B 1.96B 1.82B
Total liabilities 572.2M 1.01B 756.66M 559.73M 442.39M
Total equity 1.56B 1.58B 1.46B 1.4B 1.38B
Cash & equivalents 344.43M 809.42M 114M 123.32M 126.08M
Current assets 655.52M 1.13B 398.77M 388.52M 387.69M
Current liabilities 245.93M 717.85M 456.68M 314.9M 188.99M
Goodwill 319.26M 319.26M 319.39M 311.94M 311.94M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -291.72M 729.8M 31.91M 32.14M -207.23M
Investing cash flow -3.31M -3.32M -14.97M -14.22M -11.15M
Financing cash flow -168.92M -31.27M -25.23M -22.67M -139.56M
Change in cash -464.98M 695.42M -9.33M -2.76M -356.75M
Net income 68.31M 142.96M 82.48M 31.76M 36.77M
Kind Filing Date Link
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
form 4 Form 4 — SORAN PHILIP View Filing
form 4 Form 4 — Sterling Brian R View Filing
form 4 Form 4 — Gallo Ann C View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
form 4 Form 4 — HOLT VICTORIA M View Filing
form 4 Form 4 — SORAN PHILIP View Filing
form 4 Form 4 — TAYLOR SCOTT C View Filing
form 4 Form 4 — Sterling Brian R View Filing
form 4 Form 4 — Mitchell Robbin View Filing
form 4 Form 4 — Gallo Ann C View Filing
edgar index S-8 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 8-K — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — HOLT VICTORIA M View Filing
form 4 Form 4 — ESSIG STUART View Filing
form 4 Form 4 — SORAN PHILIP View Filing
form 4 Form 4 — TAYLOR SCOTT C View Filing
form 4 Form 4 — SCHREIER THOMAS S JR View Filing
form 4 Form 4 — Sterling Brian R View Filing
form 4 Form 4 — Mitchell Robbin View Filing
form 4 Form 4 — Gallo Ann C View Filing
edgar index 10-Q — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 144 — PIPER SANDLER COMPANIES View Filing
form 4 Form 4 — Doyle Jonathan J View Filing
form 4 Form 4 — Doyle Jonathan J View Filing
form 4 Form 4 — Doyle Jonathan J View Filing
edgar index 144 — PIPER SANDLER COMPANIES View Filing
form 4 Form 4 — Doyle Jonathan J View Filing
form 4 Form 4 — Doyle Jonathan J View Filing
form 4 Form 4 — Doyle Jonathan J View Filing
edgar index 8-K — PIPER SANDLER COMPANIES View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — PIPER SANDLER COMPANIES View Filing
edgar index 3/A — PIPER SANDLER COMPANIES View Filing
form 3 Form 3 — PELTIER JEAN-PAUL M View Filing
edgar index DEF 14A — PIPER SANDLER COMPANIES View Filing
edgar index DEFA14A — PIPER SANDLER COMPANIES View Filing
edgar index DEFA14A — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
form 4 Form 4 — SORAN PHILIP View Filing
form 4 Form 4 — Sterling Brian R View Filing
form 4 Form 4 — Gallo Ann C View Filing
edgar index SCHEDULE 13G/A — PIPER SANDLER COMPANIES View Filing
edgar index 8-K — PIPER SANDLER COMPANIES View Filing
eight k text 8-K — 8-K View Filing
edgar index ARS — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
edgar index 4 — PIPER SANDLER COMPANIES View Filing
form 4 Form 4 — HOLT VICTORIA M View Filing
form 4 Form 4 — SORAN PHILIP View Filing
form 4 Form 4 — TAYLOR SCOTT C View Filing
form 4 Form 4 — Sterling Brian R View Filing
  • Trusted by 1M+ investors
  • Global coverage
  • Real-time market data
  • Independent & unbiased

Join thousands making smarter investment decisions.

Get started for free